Matthew L. Posard - Dec 2, 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
Director
Signature
/s/ James Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Dec 2, 2022
Transactions value $
-$1,706,550
Form type
4
Date filed
12/6/2022, 06:07 PM
Previous filing
Jun 16, 2022
Next filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale -$588K -10K -7.4% $58.80 125K Dec 2, 2022 Direct F1
transaction HALO Common Stock Sale -$557K -10K -7.99% $55.74 115K Dec 5, 2022 Direct F2
transaction HALO Common Stock Sale -$561K -10K -8.68% $56.12 105K Dec 6, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.80 to $58.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2 Represents a weighted average sales price per share. The shares were sold at prices ranging from $55.70 to $55.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 Represents a weighted average sales price per share. The shares were sold at prices ranging from $56.10 to $56.19. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.